Keynote Speakers

Kenneth Aldape

Kenneth Aldape
Pathology, Mayo Clinic

  • Neuropathology
  • Molecular Genomics
  • Data Science
  • Computational Biology
Michelle Monje-Deisseroth

Michelle Monje-Deisseroth
Pediatric Neurology,
Stanford University

  • Pediatric brain tumors
  • Glioma biology
  • Neurodevelopment
  • Neuron-glia interactions
Shawn Hervey-Jumper

Shawn Hervey-Jumper
Neurosurgery, University of
California San Francisco

  • Neurosurgical oncology
  • Glioma surgery
  • Awake brain surgery
  • Brain mapping
Michael Platten

Michael Platten
Neurology, University Hospital Mannheim
EANO president

  • Neuro-immunology
  • Tumor immunology
  • Immunotherapy for brain tumors
  • Glioblastoma resistance mechanisms
Roger Stupp

Roger Stupp
Neuro-oncology, Northwestern
University Feinberg School of Medicine

  • Clinical neuro-oncology
  • Adjunct therapy modalities
  • Tumor Treating Fields
  • Clinical trial design & evidence-based oncology
Michael Weller

Michael Weller
Neurology, University Hospital Zurich

  • Clinical Neuro-Oncology
  • Neuro-immunology
  • Molecular therapeutic approaches
  • Translational neuro-oncology
Antonio Iavarone

Antonio Iavarone
Biochemistry and Molecular Biology,
University of Miami Leonard M

  • Cancer Systems Biology
  • Omics-driven Tumor Classification
  • Transcriptional Networks & Oncogenic Regulators
  • Precision Neuro-Oncology
Yusuke Nakamura

Yusuke Nakamura
National Institutes of Biomedical
Innovation, Health and Nutrition

  • Cancer Genomics
  • Personalized Medicine
  • Cancer Immunotherapy
  • Biomarker Development
Evanthia Galanis

Evanthia Galanis
Mayo clinic
SNO President

  • Clinical Neuro-Oncology
  • Clinical Trials
  • Targeted Therapy
  • Translational Therapeutics
Susan Chang

Susan Chang
UCSF

  • Clinical Neuro-Oncology
  • Adult Glioma Management
  • Molecular Biomarkers
  • Survivorship & Neurocognitive Outcomes
Patrick Wen

Patrick Wen
Harvard Medical School

  • Clinical Neuro-Oncology
  • Clinical Trials & Novel Therapeutics
  • Response Assessment
  • Translational Neuro-Oncology
Vinay K. Puduvalli

Vinay K. Puduvalli
Texas MD Anderson
Cancer Center

  • Malignant Glioma Therapeutics
  • Clinical Trials
  • Glioblastoma Tumor Microenvironment
  • Immuno-oncology
Hideyuki Saya

Hideyuki Saya
Fujita Health University

  • Cancer Stem Cells
  • CD44 Variant Biology
  • Epithelial–Mesenchymal Plasticity
  • Chemoresistance
Hideho Okada

Hideho Okada
Brain Tumor Immunotherapy Center
UCSF

  • Brain Tumor Immunotherapy
  • Cancer Vaccines
  • Tumor Immune Microenvironment
  • Translational & Clinical Immuno-Oncology
Satoru Osuka

Satoru Osuka
Neurosurgery,
The University of Alabama at Birmingham

  • Glioma Stem Cells
  • Tumor Microenvironment
  • Cell–Cell Interaction
  • Translational Neuro-Oncology
Gasper J. Kitange

Gasper J. Kitange
The Hormel Institute,
University of Minnesota

  • Glioblastoma Biology & Therapeutic Resistance
  • DNA Damage Response & Repair Pathways
  • Targeted Therapy & Radiosensitization
  • Preclinical Models for Neuro-Oncology
Nhan L. Tran

Nhan L. Tran
Mayo Clinic

  • Glioma Cell Invasion & Migration
  • Signal Transduction (EGFR / Integrin / RTK Pathways)
  • Cytoskeleton Dynamics & Cell Motility
  • Therapeutic Target Discovery in Invasive Glioma
Rintaro Hashizume

Rintaro Hashizume
Department of Pediatrics,
University of Alabama

  • Pediatric Brain Tumors
  • Epigenetic Regulation & Histone Mutations
  • Translational Therapeutics / Target Discovery
  • Tumor Biology & Developmental Context

Back to Top